Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-07-019579
Filing Date
2007-03-15
Accepted
2007-03-15 16:39:16
Documents
13
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a07-7628_110k.htm 10-K 2199465
2 EX-10.30 a07-7628_1ex10d30.htm EX-10.30 15304
3 EX-10.31 a07-7628_1ex10d31.htm EX-10.31 38267
4 EX-10.32 a07-7628_1ex10d32.htm EX-10.32 12389
5 EX-10.33 a07-7628_1ex10d33.htm EX-10.33 30528
6 EX-23.1 a07-7628_1ex23d1.htm EX-23.1 1756
7 EX-31.1 a07-7628_1ex31d1.htm EX-31.1 10379
8 EX-31.2 a07-7628_1ex31d2.htm EX-31.2 10336
9 EX-32.1 a07-7628_1ex32d1.htm EX-32.1 6381
10 EX-32.2 a07-7628_1ex32d2.htm EX-32.2 6375
11 GRAPHIC g76282kei001.jpg GRAPHIC 2252
12 GRAPHIC g76281dqi001.gif GRAPHIC 11045
13 GRAPHIC g76282kci001.jpg GRAPHIC 3248
  Complete submission text file 0001104659-07-019579.txt   2355811
Mailing Address 310 GOLDEN SHORE LONG BEACH CA 90802
Business Address 310 GOLDEN SHORE LONG BEACH CA 90802 562-628-1007
Obagi Medical Products, Inc. (Filer) CIK: 0001375247 (see all company filings)

EIN.: 954658730 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33204 | Film No.: 07696866
SIC: 2834 Pharmaceutical Preparations